Status
Conditions
Treatments
About
This is a multicentre, two-arm, randomised and controlled trial. Adults with thyroid nodules suspected of malignancy are to be included consecutively. A total of 350 patients are randomly assigned 1:1 to have FNA with a spinal (25G) or a conventional (25G) needle. The primary outcome is the rate of diagnostic cytological samples according to the Bethesda system. Secondary outcomes are diagnostic accuracy, patient's experienced pain and complication rates.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
≥18 years of age.
Patients referred for evaluation of a cold nodule on thyroid scintigraphy and with EU-TIRADS score of 3 or higher.
Clinical suspicion of thyroid cancer:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
350 participants in 2 patient groups
Loading...
Central trial contact
Tobias Andersen, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal